Omalizumab is effective in the treatment of difficult-to-treat chronic spontaneous urticaria

類似資料

• Xolair® (omalizumab) enrollment in a tertiary care allergy and asthma clinic in Canada
  著者:: Cameron, Jodi, 等
  出版事項: (2014)
• Omalizumab treatment of moderate to severe asthma in the adolescent and pediatric population
  著者:: O’Quinn, John, 等
  出版事項: (2014)
• Omalizumab in chronic spontaneous urticaria (CSU): experience in three cases
  著者:: Valle, Solange Oliveira Rodrigues, 等
  出版事項: (2015)
• 269 Refractory Chronic Urticaria Treated with Omalizumab
  著者:: Saenz, Martinez, 等
  出版事項: (2012)
• Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Common Variable Immunodeficiency
  著者:: Comberiati, Pasquale, 等
  出版事項: (2019)